Serum levels of MMP-2 (gelatinase A) are significantly elevated in stable COPD patients compared with asthmatic patients and controls, suggesting MMP-2 as a potential biomarker for COPD [96]. The gene discussed is MMP2; the disease is chronic obstructive pulmonary disease.